Delivery Order SPE2DB22D2108-SPE2DB25FU5WJ
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $36,552.67 delivery order to AmerisourceBergen Drug Corp for the supply of Advair HFA 115-21 microgram inhaler (12 grams) on September 10, 2025, with completion expected by September 11, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a discrete purchase order under AmerisourceBergen's existing pharmaceutical supply agreements with the federal government. The product will be delivered to...
- The Defense Logistics Agency awarded a $48,669.45 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 grams). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 26, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 gram units) with a ceiling value of $1,476.11. This is a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $5,586.85 to AmerisourceBergen Drug Corp for the supply of Advair HFA 230-21 microgram inhalers (12-gram units). This firm fixed price delivery order, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Advair HFA 115-21 micrograms inhalers (12-gram units) with a ceiling value of $2,208.80. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 19,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Advair HFA 115-21 micrograms inhaler in 12-gram units, valued at $9,119.12. The award is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $7,838.23 by the Defense Logistics Agency (DLA) on September 4, 2025, for the supply of Advair HFA 115-21 mcg inhaler in 12-gram units. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 5, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Advair HFA 230/21 microgram inhalers in 12-gram units, with a contract ceiling value of $1,608.05. This firm fixed-price delivery order, which is due for completion by August 29, 2025, represents a non-competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The pharmaceutical product will...
- The Defense Logistics Agency awarded a $14,025.54 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm). This is a firm fixed price delivery order with no set-aside designation, issued as a competitively awarded contract. The order is scheduled for ultimate completion by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This contract represents a single...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Advair HFA 230-21 microgram inhalers in 12-gram quantities, with a ceiling value of $1,949.58. This firm fixed-price delivery order, which is expected to be completed by April 24, 2025, represents a non-competitive set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp,...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5WJDelivery Order
The Defense Logistics Agency awarded a $19,014.36 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's consistent receipt of competitively awarded delivery orders across multiple therapeutic domains demonstrates its established capability to meet federal medical supply requirements at scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.0k | 9/17/25 |